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ABSTRACT
Bookmarking factors are transcriptional regulators
involved in the mitotic transmission of epigenetic in-
formation via their ability to remain associated with
mitotic chromatin. The mechanisms through which
bookmarking factors bind to mitotic chromatin re-
main poorly understood. HNF1 is a bookmarking
transcription factor that is frequently mutated in
patients suffering from renal multicystic dysplasia
and diabetes. Here, we show that HNF1 bookmark-
ing activity is impaired by naturally occurring mu-
tations found in patients. Interestingly, this defect
in HNF1 mitotic chromatin association is rescued
by an abrupt decrease in temperature. The rapid re-
localization to mitotic chromatin is reversible and
driven by a specific switch in DNA-binding ability of
HNF1 mutants. Furthermore, we demonstrate that
importin- is involved in the maintenance of the mi-
totic retention of HNF1, suggesting a functional
link between the nuclear import system and the mi-
totic localization/translocation of bookmarking fac-
tors. Altogether, our studies have disclosed novel as-
pects on the mechanisms and the genetic programs
that account for the mitotic association of HNF1,
a bookmarking factor that plays crucial roles in the
epigenetic transmission of information through the
cell cycle.
INTRODUCTION
Mitosis is a moment of drastic changes in the organiza-
tion of the cell. At nuclear envelope breakdown, the loss
of nuclear compartmentalization leads to a massive release
and diffusion of most of the soluble nuclear constituents
in the cytoplasm (1). At the same time, the typical pro-
gressive chromatin compaction, starting at the beginning of
prophase (2), leads to the characteristic transcriptionally in-
active status of condensed mitotic chromosomes. The faith-
ful transmission and reactivation of genetic programs after
mitosis is considered a key issue in regard to the epigenetic
inheritance of the cellular identity.
While most nuclear factors dissociate from mitotic chro-
mosomes, the observation that certain transcription fac-
tors remain associatedwithmitotic chromatin suggested the
idea that mitotically retained factors could represent or de-
liver an epigenetic memory signal (bookmarking) through-
out mitosis (3). In recent years, it has been demonstrated
that the impairment of the function of specific bookmark-
ing factors can result in delayed (4–7) or impaired (8) re-
expression of target genes after a cell cycle. Relatively little is
known about the mechanisms through which specific tran-
scription factors are able to persist on mitotic chromatin,
and thus act as bookmarking factors.
We have previously demonstrated that Hepatocyte Nu-
clear Factor 1  (HNF1) is a bookmarking factor (8).
HNF1 (also known as vHNF1 or LF-B3) is a POU-
homeobox transcription factor that is expressed since the
first steps of kidney, pancreas and liver development (9–11).
Mutations inHNF1B, the gene encoding for HNF1, have
been shown to be responsible for ‘Maturity Onset Diabetes
of the Young 5’ (MODY5) (12), a monogenic form of type
2 diabetes. More recently, a number of studies have shown
that mutations in HNF1B are the first genetic cause of
Congenital Abnormalities of Kidney and Urogenital Tract
(CAKUT) (13,14). With the use of mouse models, we have
previously shown that the inactivation of HNF1 (Hnf1b)
during the intense proliferation phase that accompanies the
tubular elongation in kidneys of perinatal mice, results in
severe polycystic disease. In this model, the formation of
cysts is due to the loss of expression of several target genes
that are often mutated in patients suffering from renal cysts
(8,15,16). Interestingly, when Hnf1b is inactivated in quies-
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cent renal cells (starting from postnatal-day 10) the expres-
sion of its typical cystic target genes is maintained at nor-
mal levels and animals do not develop cysts (8). However,
HNF1 cystic target genes become transcriptionally silent
when HNF1-deficient cells are forced to pass through mi-
tosis (8). The analysis of histone methylation and acetyla-
tion status in post-mitotic cells indicated that the chromatin
of HNF1 target genes acquires heterochromatin marks
(8). The observation that HNF1 proteins remain associ-
ated with mitotic chromatin indicated that HNF1may act
as a bookmarking factor. The mechanisms that drive the
specific mitotic chromatin association of HNF1 are still
poorly understood.
In the present study, we attempted to characterize the na-
ture of the interactions that ensure the retention of HNF1
on mitotic chromatin. For this purpose, we characterized
several mutations occurring in patients. Our results showed
that the DNA binding ability of HNF1 is absolutely re-
quired for proper mitotic retention. Interestingly, we have
shown that the loss of the mitotic binding of specific mu-
tants is temperature-sensitive since a sudden drop of tem-
perature can restore mitotic localization. In addition, we
demonstrated that the mitotic localization is mediated by
the importin- system. Our results disclose an unexpected
highly dynamic nature of the binding of HNF1 to mitotic
chromatin.
MATERIALS AND METHODS
Cell culture
mIMCD3 cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM) medium (Life Technologies) sup-
plemented with 10% fetal bovine serum (FBS) serum (Life
Technologies) and 1% penicillin/streptomycin (Life Tech-
nologies) and transfected with JetPei (Polyplus Trans-
fection). MDCK cells stably expressing inducible Nter-
HNF1-GFP wild-type and mutants were generated us-
ing a Tet-ON system. MDCK cells expressing the repres-
sor pcDNA6/TR, a kind gift of Yasuyuki Fujita (Uni-
versity College, London, UK) (17), were maintained in
DMEMmedium containing 10%FBS serum, 1% pen/strep
and blasticidin (5 g/ml) (Sigma). pcDNA4/TO/HNF1b-
GFP constructs were transfected in MDCK-pcDNA6/TR
cells using JetPei. After selection with blasticidin (5 g/ml)
(Sigma) and zeocin (400 g/ml) (Life Technologies), sin-
gle clones were isolated using cloning cylinders (Fisher Sci-
entific). GFP expression was induced by adding 1 g/ml
Doxycycline (Sigma) to the culture medium.
Plasmids
The sequence of oligonucleotide primers is indicated in Sup-
plementary Table S1. For the construction of the Nter-
HNF1-GFP fusion plasmid (house name 10p5), the N-
terminal part of the human HNF1 isoform A (amplifi-
cation codon 1–313) was amplified by polymerase chain
reaction (PCR) on the 6p15 plasmid, containing the hu-
man cDNA of HNF1B isoform A (18), with 10i1 and 10i2
primers. The amplicon was ligated with the pEGFP-N1
plasmid (Roche) after digestion by Asp718 and NheI. For
constructingHom (house name 10p3), a PCRwas carried
out on the 6p15 plasmid, containing the human cDNA of
HNF1B isoformA (18), with the primers 10i1 and 10i3 (am-
plification from codon 1 to 236). The obtained amplicon
was ligated with the pEGFP-N1 plasmid (Roche) after di-
gestion by Asp718 and NheI. For the construction of H3
(house name 10p7), a PCR was carried out on the 6p15
plasmid, containing the human cDNA of HNF1B isoform
A (18) with the primers 10i1 and 10i4 (amplification from
codon 1 to 291). The obtained amplicon was ligated with
the pEGFP-N1 plasmid (Roche) after digestion by Asp718
and NheI. For the construction of the pcDNA4/TO/Nter-
HNF1-GFP (house name 11p40), the ORF of HNF1-
GFP from 10p5 into pcDNA4/TO was digested by NheI
and NotI. Blunt ends were created with the Klenow poly-
merase. pcDNA4/TO was digested by HindIII and ApaI,
and blunt ends were created by using the T4 DNA poly-
merase (Promega). After ligation and transformation in
DH5alpha cells (Life technologies), clones were tested by
PCR. Positives clones were sequenced on the full ORF of
HNF1-GFP. For the construction of Nter-HNF1-GFP
(house name 09p23), a PCR was carried out on the 09p19
plasmid, containing the human cDNA of HNF1A (isoform
A) with the primers 10i5 and 10i6. The amplicon was lig-
ated with the pEGFP-N1 plasmid (Roche) after digestion
by Asp718 and NheI.
Mutagenesis
To introduce point mutations in Nter-HNF1-GFP, we
used the QuickChange II protocol (Agilent). In sum-
mary, 20 cycles of PCR were carried on pcDNA4TO/Nter-
HNF1 with Pfu polymerase (Promega) and a specific
set of primers (P256S: 11i122 and 11i123; V265L: 13i94
and 13i95; G287S: 12i64 and 12i65, Supplementary Ta-
ble S1). Amplicons were ethanol-precipitated and digested
over-night by 1 Unit of DpnI at 37◦C, and then trans-
formed into DH5alpha cells (Life technologies). Positive
clones were sequenced on the full Nter-HNF1-GFP ORF,
and subcloned by a SpeI/BamHI digestion in the original
pcDNA4TO/Nter-HNF1.
Immunofluorescence
mIMCD3 cells were plated on coverslips in 6-well plates
and fixed with 4% formaldehyde (Electron Microscopy
Sciences) for 15 min at room temperature or with cold
methanol for 15 min at −20◦C. After fixation, cells were
rinsed three times in phosphate buffered saline (PBS),
blocked in 3% bovine serum albumin for 1 h at room tem-
perature and incubated with HNF1b antibodies (sc22840,
Santa Cruz, 1/1000) in blocking solution overnight at 4◦C.
For cells fixed in formaldehyde, a step of permeabiliza-
tion (5 min with 0.2% Triton X-100) was performed be-
fore blocking. After washing in PBS, cells were incubated
with secondary antibodies (Alexa Fluor donkey anti-rabbit
488, Life Technologies, 1/1000) for 1 h at room temper-
ature, counterstained with DAPI (Life Technologies) and
mounted with Fluoromount G (Interchim). MDCK cells
over-expressing Nter-HNF1-GFP wild-type and mutants
were processed as above, except that no antibody incuba-
tion was performed. Confocal images were acquired with
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a Leica DMI6000 spinning disk using a CoolSNAP HQ2
camera (Photometrics).
Videomicroscopy
For live-cell imaging and time-lapse experiments, cells were
grown on IBIDI dishes (35 mm, IBIDI), counterstained
withHoechst 33342 (Life Technologies) and imagedwith an
Axiovert 200M microscope (Zeiss) equipped with a Cool-
SNAPHQ camera (Photometrics) in a chambermaintained
at 37◦C and with 5% CO2. For temperature shift experi-
ments, IBIDI dishes (35 mm) with 1 ml of medium at either
20◦C or 37◦C were left to reach thermic equilibrium and
then imaged. Temperature shifts were obtained by adding
1 ml of medium at either 4◦C or 50◦C and rapidly mixed.
Real-time temperature measurements were simultaneously
obtained using three probes (Lm35dz) immersed in the cell
culture medium and connected to a ATmega328P micro-
controller (Arduino card). Importazole (50 M) or vehicle
(DMSO) (Sigma) were diluted in regular culture medium
and added to the cells 20 min before cold shock.
Western blot
A total of 30 g of nuclear extracts were run on 4–15%
precast gels (Biorad), transferred on nitrocellulose mem-
branes (GE Healthcare) and immunoblotted using anti-
bodies against GFP at 1/5000 (ab290, Abcam), or Pol2
at 1/2000 (8WG16, BioLegend). Detection was performed
with ECL Prime reagent (GE Healthcare) and the Fusion
FX imaging system (Vilber Lourmat).
EMSA
Two or three micrograms of nuclear extracts prepared
as described in (19) were used for each binding reac-
tion, in 10 mM HEPES, 30 mM KCl, 5 mM DTT,
Glycerol 10%, 9 mM Spermidine, 9 mM MgCl2 and
variable amounts of 32P-labelled double stranded
HNF1probe (CTTTAGTTAATATTTGACAGTTT/
AAACTGTCAAATATTAACTAAAG (20)), in a total
volume of 20 l. Homologous/Heterologous competition
controls were realized by adding a 30-fold excess of double
stranded cold HNF1 probe, or a double stranded oligonu-
cleotide with an arbitrarily chosen non-related sequence
(GGCTGAAGTCCAAAGTTCAGTCCCTTCGCT
A/TAGCGAAGGGACTGAACTTTGGACTTCAGCC
corresponding to the HNF4alpha binding site in the prox-
imal promoter of Hnf1a), respectively. Binding reactions
were incubated on ice or at 38◦C for 15–20 min. Gels, 6%
acrylamide-0.25× TBE, were pre-run at 6V/cm for 15–20
min, at 4◦C or at 38◦C. Binding reactions were loaded into
the gels and run in an electric field of 6V/cm for 1 h. Gels
were fixed in a 10% Ethanol 10% Acetic-Acid solution for
10 min, dried, exposed with a phosphor-imager screen and
revealed with a Typhoon phosphor-imager scanner. For
4◦C experiments, the binding reactions were established on
ice, and the electrophoretic mobility shift assays (EMSAs)
were carried out at 4◦C, with pre-cooled acrylamide gels
and running buffer. For 38◦C experiments, the binding
reactions were incubated at 38◦C and the electrophoresis
was carried out in an incubator at 38◦C, with pre-heated
acrylamide gels and running buffer. The intensity of the
bands was measured with ImageJ. Saturation curves were
analysed with GraphPad Prism version 6 (Graphpad
software, La Jolla, CA, USA, www.graphpad.com).
Chromatin immunoprecipitation
MDCK cells stably expressing inducible Nter-HNF1-
GFP wild-type and mutants were induced with 50–100
ng/ml Doxycycline for 3 h and crosslinked with 0.5%
Formaldehyde (Sigma) at 37◦C for 10min. Crosslinkingwas
stopped by the addition of 125 mM Glycine (final concen-
tration). After washing with ice-cold PBS, cells were col-
lected in Lysis buffer (25 mM Tris–HCl pH 8.0, 2 mM
ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl,
1%TritonX100, 0.3% sodium dodecyl sulphate (SDS), Pro-
tease inhibitors (Roche)). Sonication was performed on a
Bioruptor Pico (Diagenode). A total of 7–10 g of chro-
matin were used for immunoprecipitation in ChIP buffer
(25 mM Tris–HCl pH 8.0, 2 mM EDTA, 150 mM NaCl,
1% Triton X100, 0.1% SDS, protease inhibitors) with 2
g of GFP antibody (ab290, Abcam) or rabbit IgG (sc-
2027X, Santa Cruz), bound to 50 l of Dynabeads pro-
tein A (Life Technologies), overnight at 4◦C. Beads were
washed with five successive different washing buffers (I:1%
TRITON, 0.1% Sodium Deoxycholate, 150 mM NaCl, 10
mM TRIS–HCl pH8; II: 1% NP-40, 1% Sodium Deoxy-
cholate, 150 mM KCl, 10 mM TRIS–HCl pH8; III: 0.5%
TRITON, 0.1% Sodium Deoxycholate, 500 mM NaCl, 10
mM TRIS–HCl pH8; IV: 0.5% NP-40, 0.5% Sodium De-
oxycholate, 250 mM LiCl, 20 mM TRIS–HCl pH8, 1 mM
EDTA; V: 0.1% NP-40, 150 mM NaCl, 20 mM TRIS–HCl
pH8, 1 mMEDTA) and twice with TE buffer (10 mMTris–
HCl pH8, 1 mM EDTA pH8). Beads were then incubated
with Elution Buffer (1% SDS, 0.1M NaHCO3, 100 mM
NaCl) for 1 h at room temperature and overnight at 65◦C,
after addition of 20 g/ml RNase A, along with the In-
puts. De-crosslinked extracts were treated with 100 g/ml
proteinase K at 55◦C for 1–2 h. DNA was extracted with
QIAquick PCR Purification Kit (Qiagen) and analysed by
qRT-PCR with an MX3005P machine (Stratagene) using
FastStart SYBR Green (Roche). Primer sequences are pro-
vided in Supplementary Table S2.
Primary urinary renal epithelial cell (UREC) culture prepa-
ration
Subjects included a patient carrying a heterozygous point
mutation (c.[766C > T];[ = ] p.[Pro256Ser];[ = ]) in exon
3 of HNF1B gene and a healthy subject. The patient pre-
sented with normal-sized kidneys with bilateral cortical
cysts and a normal glomerular filtration rate (14). Patient
urine sample was collected after written informed consent
(frompatient and parents) through theReference Center for
Rare Diseases MARHEA (Maladies Re´nales He´re´ditaires
de l’Enfant et de l’Adulte), in the frame of our collection
‘Ne´phropathies he´re´ditaires––Antignac/Saunier’ declared
to the French Ministry of Research in March 2015 under
the number DC 2014–2272 and which obtained an approval
of the ethical Committee ‘CPP Ile-de-France II’ on 10 June
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2015. The cells were prepared according to the protocol de-
scribed in (21) and (22). After the second passage, cells were
plated for the immunofluorescence experiments on 12 mm
coverslips in two 24-well plates. After 2 days of culture, for
the temperature shift experiments some plates were incu-
bated at room temperature for 30 min and processed for
immunostaining with methanol fixation as described above,
along with the control plates (kept at 37◦C).
Statistical analysis
All statistical tests (Mann–Whitney, paired t-test and
Kruskal–Wallis) were performed on GraphPad Prism ver-
sion 6 (Graphpad software, La Jolla, CA, USA, www.
graphpad.com).
RESULTS
The DNA-binding domain of HNF1 is essential for mitotic
chromatin association
HNF1 together with HNF1 constitute a digenic fam-
ily of dimeric POU-Homeobox transcription factors, struc-
tured in three functional parts: an N-terminal dimerization
domain, a DNA-binding domain and a C-terminal trans-
activation domain (Figure 1A). The DNA-binding domain
consists of a POU-specific domain (POUs), composed of
five -helices and of a homeodomain (POUh) (23,24). We
have previously shown that the N-terminal part of HNF1
(including the dimerization and theDNA-binding domain),
when fused toGFP (Nter-HNF1-GFP), is capable of driv-
ing a robust mitotic chromosomal localization ((8), Figure
1B and Supplementary Movie S1). The nature of the inter-
action of HNF1 with mitotic chromatin could have been
potentially ascribed to a spurious association of the pro-
tein with the highly condensed mitotic chromatin structure,
not necessarily relying on a functionalDNA-binding capac-
ity. In order to verify this possibility, we monitored the ef-
fect of deletions known to disrupt the ability of HNF1 to
bind to DNA. First, we constructed a GFP-fusion version
of HNF1 carrying a deletion of the entire homeodomain
(Hom) (Figure 1C and Supplementary Figure S1). It is
known that the homeodomain of HNF1 plays an essen-
tial role in DNA binding (23). This deletion did not per-
turb the sub-cellular localization of the GFP-fusion pro-
tein in interphase, suggesting that it retained an efficient nu-
clear localization signal. In fact, the fluorescence signal was
tightly localized in the nucleus, to an extent that was per-
fectly comparable to the degree of nuclear localization of
the wild-type GFP-fusion protein (Figure 1C). Using time-
lapse microscopy, we showed that the Hom mutant sud-
denly becomes cytoplasmic in <30 s following the nuclear
envelope breakdown at prometaphase (Figure 1C and Sup-
plementary Movie S2). Next, we tested the effect of a more
limited deletion specifically affecting the third helix of the
homeodomain (H3) (Supplementary Figure S1). This he-
lix is known to specifically interact with nucleotides in the
major groove of the DNA (23). Again, our results showed
that the deletion of these 22 amino acids dramatically im-
paired mitotic chromatin-binding of the protein (Figure 1D
and Supplementary Movie S3).
Figure 1. Effect of deletion mutations of the DNA-binding domain on
mitotic chromatin binding of HNF1. (A) Scheme of the structural orga-
nization of HNF1. DIM: dimerization domain, POUs: POU-specific do-
main, POUh: homeodomain. The coordinates of the amino-acid sequence
are indicated in the scheme. (B–D) Time-lapse microscopy of cells express-
ing Nter-HNF1-GFP wild-type (in MDCK) (B) and HOM-GFP (C),
or H3-GFP (D) in IMCD3 transfected cells. For each fusion protein,
green fluorescence (GFP) and phase contrast (PC) are shown for crucial
time points of mitosis. NEB is the moment of the nuclear envelope break-
down. Time (in minutes) is indicated for each frame at the bottom right
corner. White arrows indicate the cell undergoing mitosis, and the nuclei
of the daughter cells after cytokinesis. Scale bars, 10 m.
In order to verify that the observed mitotic localization
was also a characteristic of the endogenously expressed pro-
tein, we monitored the sub-cellular localization of the en-
dogenously expressed HNF1 in renal cell lines (Figure 2).
Surprisingly, our results showed that in formaldehyde-fixed
cells, the immunofluorescence signal corresponding to the
endogenous protein was completely excluded from the mi-
totic chromatin (Figure 2B, upper panel). This apparent dis-
crepancy led us to assess the possible effect of fixation on
the mitotic localization of the Nter-HNF1-GFP. Indeed,
we found that when cells expressing the GFP-fusion protein
were fixed under the same conditions (4% formaldehyde fix-
ation for 15 min at room temperature), we observed the sys-
tematic exclusion of the GFP signal from mitotic chromo-
somes and dispersal of the protein in the cytoplasm (Fig-
ure 2B, lower panel). This suggested that a formaldehyde-
based fixation disrupted the association of the protein with
the chromosomes during mitosis. We therefore tried to find
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Figure 2. Effect of fixation on the mitotic localization of HNF1. (A) Mi-
totic localization of Nter-HNF1-GFP fusion protein detected through
the fluorescence of the GFP moiety with confocal microscopy in live
MDCK cells. (B) Effect of formaldehyde (4%) fixation on themitotic local-
ization of HNF1. Shown above is the endogenously expressed HNF1 in
IMCD3 cells detected with an HNF1 specific antibody. Shown below is
the GFP fluorescence of the Nter-HNF1-GFP fusion protein in MDCK
cells. (C) Effect of methanol fixation. Shown above is the localization of the
endogenously expressedHNF1 in IMCD3 cells detected with anHNF1
specific antibody. Shown below is the confocal GFP fluorescence of the
Nter-HNF1-GFP fusion protein in MDCK cells. DNA (red signal) was
stained with DAPI (fixed cells) or Hoechst 33 342 (live cells). White arrows
indicate the position of the mitotic cells. Scale bars, 10 m.
an alternative fixation protocol that could preserve the lo-
calization ofNter-HNF1-GFP as observed in live cells. In-
terestingly,methanol fixation (at either−20◦Cor room tem-
perature for 15 min) led to the complete preservation of the
mitotically-bound HNF1, either in fusion with the GFP
or in cell lines that express HNF1 endogenously (Figure
2C).
All these results suggest that a minimal mitotic-module
of HNF1 corresponding to the first 313 amino-acids in
the N-terminal part contains a DNA-binding domain that
is absolutely required for mitotic chromosomal binding. In
addition, the endogenously expressed full-length protein (in
renal cells) follows the same behaviour than that of GFP fu-
sion constructs.
The impact of humanMODYmutations onmitotic chromatin
binding
One of the possible difficulties in the interpretation of re-
sults obtained with proteins carrying deletions is that these
mutations may dramatically modify the global structure of
the protein to an extent that could have prevented their abil-
ity to bind mitotic chromatin, independently from the loss
of their specific DNA binding capacity. In order to take
into account this consideration, we decided to assessmitotic
binding of HNF1 protein by examining single amino-acid
substitutions. The genes encoding for HNF1 and HNF1
(HNF1A and HNF1B, respectively) are frequently mutated
in diabetic and renal cystic patients (12,14,25,26). The vast
majority of these mutations is likely to encode for hypomor-
phic or null variants, since the phenotype of the patients
carrying thesemutations resembles that presented bymouse
models carrying nullmutations ofHnf1a andHnf1b, respec-
tively. Therefore, we may reasonably assume that the mu-
tations observed in these patients might imply the impair-
ment of some functions. A considerable number of these
mutations (23,24,27,28) are localized in theminimal mitotic
module described above, conferring chromosomal mitotic
binding toGFP-fusion proteins. HNF1 andHNF1 share
a particularly strong homology in this functional domain
with 62% identity and 80% similarity. In addition, the three-
dimensional structure of these two proteins, in this domain,
is almost identical given the fact that the protein structures
superimpose verywell with a root-mean-square deviation of
atomic positions in the backbone atoms in the order of only
1 Angstro¨m (23,24). Furthermore, in HNF1-deficient em-
bryonic stem cells, the forced expression of HNF1 rescues
the function played by HNF1 (29), suggesting that the
two transcription factors may share common specific bind-
ing sites on the genome. In fact, in EMSAs, both HNF1
and HNF1 bind to a common consensus motif with sim-
ilar affinities (9). To further assess the functional similarity
of the two proteins, we monitored the capacity of HNF1
to bind to mitotic chromatin. As previously described (30),
we confirmed that when fused to the GFP, the correspond-
ing minimal N-terminal functional mitotic binding module
of HNF1 had an intrinsic defective nuclear localization
in interphase cells (Supplementary Figure S2). In fact, in
interphase cells, a considerable amount of the protein was
localized in the cytoplasm. Nevertheless, upon nuclear en-
velope breakdown, we could not detect any significant in-
crease in the intensity of the signal in the cytoplasm. When
we inspected the possible associationwith chromosomalmi-
totic barrels, we could systematically see a clear association
of HNF1-GFP with mitotic chromatin indicating that the
corresponding minimal mitotic-module of HNF1 shares
with HNF1 the ability to remain associated to mitotic
chromatin (Supplementary Figure S2).
Given the fact that a considerable number of MODY3
and MODY5 mutations map to this functional mitotic-
module, it was interesting to investigate if some of themmay
have impaired mitotic binding. In order to test this possi-
bility we selected, from the pool of known mutations that
occur in MODY3 and MODY5 patients, amino-acid sub-
stitutions that involved residues particularly well conserved
in both HNF1A and HNF1B and across different species
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Figure 3. Mitotic chromatin localization defect of MODY mutants. Live
imaging of MDCK cells expressing Nter-HNF1-GFP (WT or MODY
mutants) counterstained with Hoechst 33342 (red signal, DNA).White ar-
rows indicate the position of the mitotic cells. Scale bar, 10 m.
throughout evolution, and that were not necessarily clearly
involved in DNA binding. Then, we introduced by directed
mutagenesis the amino-acid substitutions corresponding to
the selected human mutations in the minimal mitotic mod-
ule of Nter-HNF1-GFP fusion that, per se, has a very ro-
bust basal interphase nuclear localization.We then assessed
the effect of these mutations on the ability of Nter-HNF1-
GFP fusion protein to bind to mitotic chromatin. The first
two mutations that we tested (G255S (28) and V233L (31))
were identified in MODY3 (HNF1) patients and corre-
spond to positions G287S and V265L in HNF1, respec-
tively. The third one (P256S) was found in an HNF1B pa-
tient presenting bilateral cortical renal cysts (14). Our re-
sults showed that the three mutant proteins were efficiently
localized to the nucleus in interphase cells (Figure 3). Dur-
ingmitosis, themutationG287S did not strongly impair mi-
totic localization whereas the other two (P256S and V265L)
were completely excluded from mitotic chromatin, indicat-
ing that they drastically impaired mitotic binding (Figure
3).
Thermosensitivity of MODY mutants
Strikingly, we discovered that the extent of mitotic chro-
matin binding of P256S and V265L mutant proteins was
significantly affected by the temperature conditions in
which the cells were set. The extent of mitotic chromatin
retention of the wild-type Nter-HNF1-GFP fusion pro-
tein and of the G287S mutant was essentially unaltered
over a relatively wide range of temperatures with chromo-
somal barrels intensely decorated by the HNF1 fusion
protein (Supplementary Figures S3 and 4). On the other
hand, P256S and V265L mutant fusion proteins showed a
marked decreased binding to mitotic chromatin with the in-
crease in temperature. For example, the P256S mutant pro-
tein was completely dissociated from mitotic chromatin at
temperatures above 30–32◦C (restrictive temperature) (Fig-
ure 4A). When tested at temperatures below these critical
values (permissive temperature), P256S mutant protein was
associated with mitotic chromatin (Figure 4A). The V265L
mutant followed the same transition, with a higher tem-
perature switch around 36–37◦C (Figure 4B). This strik-
ing effect of temperature transition allowed us to unmask
an unpredicted high degree of rapid re-localization of mu-
tant fusion proteins, upon abrupt temperature shifts. In
fact, our live imaging experiments (with the use of in situ
temperature sensors following the temperature changes in-
duced by the addition of cold or hot medium) indicated that
thermo-sensitive mutant proteins rapidly re-localized tomi-
totic chromatin after a sudden decrease of temperature (Fig-
ure 4A and B), or were dispersed in the cytoplasm after a
rapid increase of temperature (Figure 4C andD). It is worth
noting that when cells over-expressing these temperature-
sensitive mutations were grown at restrictive temperature,
the localization of the signal was perfectly nuclear (Fig-
ure 4A and B). With the use of the ‘Intensity Correlation
Quotient’ (ICQ) method (32), we could measure the aver-
age extent of mitotic binding of these mutants. Our results
showed that on average, both P256S and V265L mutants
exhibited a significantly lower ICQ (at 37◦C), in respect to
wild-type Nter-HNF1-GFP or the G287S mutant, con-
firming a drastic mitotic delocalization (Figure 4E). On the
other hand, at room temperature (25◦C) we could not see
any significant difference of ICQs between WT and mu-
tant Nter-HNF1-GFP (Figure 4F). In order to validate
the pertinence of these observations we decided to assess the
mitotic binding ability ofHNF1 directly in renal cells from
a CAKUT patient carrying a heterozygous (P256S) muta-
tion (14). To this end, we established primary urinary renal
epithelial cell cultures (URECs) and assessed the mitotic
localization of the endogenously expressed HNF1 pro-
tein, presumably composed by a mixture of heterodimers
(WT:P256S) and homodimers (WT:WT and P256S:P256S).
Immunofluorescence on mitotic patient cells cultured at re-
strictive temperature (37◦C) showed a modest but signifi-
cant and visible delocalization of HNF1 signal in the cy-
toplasm, compared to the healthy control cells (Figure 5A
and C). The rather modest entity of the delocalization de-
fect is probably related to the fact that this mutation is
heterozygous. When these cells were incubated at permis-
sive temperature (25◦C) for 30 min before immunofluores-
cence, HNF1 signal was observed bound to mitotic chro-
mosomes similarly to what is observed in the URECs from
a healthy control (Figure 5B and D).
Temperature shifts affect DNA binding ability
The profound effect of temperature transition on mi-
totic binding indicated that these mutations may induce
temperature-dependent conformational changes that im-
pair mitotic chromatin binding. In order to monitor if these
putative conformational changes might have directly af-
fected DNA binding, we evaluated the ability of mutant
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Figure 4. MODYmutations are thermosensitive. (A–D) Effect of abrupt temperature variation on the mitotic chromatin localization ofMODYmutations
in Nter-HNF1-GFP fusion protein (green signal) expressed in MDCK cells (red signal, DNA). The temperature in the medium was measured with three
independent probes, as shown by the temperature curves. Black arrows indicate the moment in which the picture was taken. P256S and V265L mutants,
when grown at restrictive temperature, were dissociated from mitotic chromatin. However, they rapidly re-associated to mitotic chromatin upon sudden
temperature drop (panels A and B). Conversely, they rapidly dissociated from mitotic chromatin when temperature was rapidly raised (panels C and D).
White arrows indicate the position of the mitotic cells. Scale bars, 10 m. (E and F) Quantification of the ‘Intensity Correlation Quotient’ (ICQ) between
Hoechst andGFP signals at 37◦C (panel E) or at room temperature (panel F), in mitoticMDCK cells stably expressingNter-HNF1-GFPWT ormutants.
WT 37◦C, n = 34; G287S 37◦C, n = 32; P256S 37◦C, n = 32; V265L 37◦C, n = 35; WT 25◦C, n = 30; G287S 25◦C, n = 34; P256S 25◦C, n = 26; V265L
25◦C, n = 31. Statistical significance was determined by Kruskal–Wallis test followed by Dunn’s multiple comparisons test. ***P < 0.0001.
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Figure 5. Primary urinary renal epithelial cells (URECs) from a healthy subject (WT) and a patient carrying a heterozygous mutation of P256S inHNF1B
gene. (A) Mitotic localization of endogenous HNF1 (green) in heterozygous (P256S) or WT URECs at 37◦C. (B) Mitotic localization of endogenous
HNF1 (green) in heterozygous P256S or WTURECs at low temperature (25◦C). Scale bar, 10 m. (C andD) Quantification of the ‘ICQ’ between DAPI
and GFP (HNF1) signals at 37◦C (panel C) or at 25◦C (panel D), in mitotic URECs. Statistical significance between WT (n = 35) and P256S (n = 24) at
37◦C, and between WT (n = 14) and P256S (n = 16) at 25◦C was determined by Kruskal–Wallis test followed by Dunn’s multiple comparisons test. *P <
0.05.
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proteins to bind DNA by EMSA in temperature-controlled
conditions. We optimized a protocol for EMSA to moni-
tor DNA-binding saturation curves for Nter-HNF1-GFP
wild-type andmutants in nuclear extracts from stably trans-
fected inducibleMDCK cells. Our results showed that when
the DNA–protein complexes were electrophoretically sepa-
rated at low temperature (4◦C), the sequence-specific DNA
binding characteristics of P256S and V265L were compa-
rable to that of the wild-type protein (Figure 6A). How-
ever, when the same extracts were incubated and elec-
trophoretically separated at restrictive temperature condi-
tions (38◦C), a drastic decrease in specific shifts could be ob-
served for these two mutants compared to the control wild-
type protein (Figure 6A). These defects were confirmed by
the comparison of saturation curves (Figure 6B). The ob-
served drastically reduced binding was not due to degrada-
tion of the proteins since western blot experiments showed
that all these extracts (heated or not) contained equivalent
amount of HNF1 protein compared to controls (Figure
7A). Moreover, when nuclear extracts were temporarily in-
cubated at 38◦C for 20 min and then cooled down at 4◦C,
mutant proteins recovered their binding activity since they
gave rise to shifts comparable to those obtained with the
wild-type protein (Figure 7B). Interestingly, the peculiar re-
versible aspect of the binding of the MODY mutants to
DNA was a dynamic and reversible phenomenon also in
live cells. In fact, the fluorescence of the GFP fusion pro-
tein in live cells consistently dissociated from mitotic chro-
mosomes upon a rise of the temperature and systematically
re-associated to mitotic chromosomes when the tempera-
ture was again set to a lower level (Figure 7C and Supple-
mentary Movie S4).
All these results suggest that at restrictive temperature,
P256S and the V265L mutant proteins undergo a reversible
conformational change that preventsDNAbinding. Similar
to the phenotypic effect of Hom or H3 deletion muta-
tions, the loss of the ability to bind DNA leads to a sud-
den loss of mitotic chromatin binding. When the confor-
mational change due to an increase of the temperature is
induced, it takes only few seconds for the protein to be dis-
persed in the cytoplasm and, conversely, only few seconds
to re-associate to mitotic chromatin when rapidly cooled
down.
In order to verify if these mutants were able to bind chro-
matin, we performed ChIP assays on stably transfected in-
ducibleMDCK cells.We identifiedHNF1 binding sites that
are highly conserved throughout evolution using a previ-
ously described in silico approach (33). Our results demon-
strated that the mutant proteins had only a slightly de-
creased binding activity. In fact, in spite of the drastic defect
of their DNA binding activity in EMSA, the two mutants
were still able to bind the promoters of two of HNF1’s tar-
get genes, PKHD1 and HNF1B itself (Supplementary Fig-
ure S5).
HNF1 mitotic re-association is impaired by importazole
The thermosensitive nature of the phenotype observed with
these MODY mutant proteins allowed us to characterize
some critical aspects concerning the chromatin recruitment
of HNF1 to mitotic chromatin. In particular, the extreme
rapidity of the thermosensitive re-association of MODY
mutant proteins suggested that such a translocation might
be mediated by an active process. It is known that the Ran-
GTP/Ran-GDP cycle plays an essential role in the cytoplas-
mic to nuclear transport by regulating the interactions be-
tween cargos and nuclear transport receptors including, for
example, those of the importin- family (34,35). The com-
mon principle underlying this function is the anisotropy
of the distribution of the Ran-GTP gradient driven by the
chromatin associated guanine nucleotide exchange factor
RCC1. Interestingly, it has been shown that RCC1 and
Ran-importin- system also plays an important role in the
spatio-temporal regulation of mitosis, in particular con-
cerning mitotic-spindle assembly factors (36). We therefore
inspected the effect of the inhibition of the importin- sys-
tem on the recruitment of HNF1 mutant fusion protein
to mitotic chromatin with the use of importazole, a specific
inhibitor of importin- (37). In order to avoid the toxic ef-
fect of importazole (on nuclear compartmentalization and
possibly on cell cycle), we treated our cells for a relatively
short period of time (20 min) before observation, to be able
to monitor cells that had already been engaged in mitosis.
Our results showed that such a short treatment did not in-
terfere with the nuclear localization of either wild-type or
mutant HNF1 protein in interphase (Supplementary Fig-
ure S6). However, the mitotic chromatin re-association of
the P256S mutant, after cold shock, was dramatically de-
layed and globally decreased in its extent, indicating that
the importin- system seems to be involved in the mitotic
chromatin recruitment of our GFP fusion protein (Figure
8A). In fact, the statistical analysis of our results showed a
very significantly decreased ICQ in importazole treated cells
(Figure 8B).
DISCUSSION
In recent years, the study of the functions played by tran-
scription factors has disclosed some novel crucial aspects
on the epigenetic control of gene expression. Several tran-
scription factors were shown to be involved in the mitotic
transmission of epigenetic information. Mitosis is charac-
terized by a dramatic reorganization of the nuclear struc-
ture. The typical progressive chromatin condensation is ac-
companied by the loss of nuclear envelope integrity. This
leads to the cytoplasmic diffusion of many nuclear com-
ponents, including most transcription factors that dissoci-
ate from the typically condensed mitotic chromatin. These
phenomena lead to a genome wide silencing of gene ex-
pression. Aftermitosis, daughter cells must faithfully reacti-
vate their genetic programs in order to ‘remember’ and pre-
serve their identity. Interestingly, some transcription factors
have the ability to remain bound to mitotic chromatin and
play important roles in the epigenetic transmission of regu-
latory information through mitosis. This concept has been
defined as ‘mitotic bookmarking’. However, relatively little
is known about the way bookmarking factors vehicle this
form of epigenetic transmission. In particular, the molec-
ular mechanisms that endow bookmarking transcription
factors their ability to remain associated to mitotic chro-
matin remain poorly understood. Our previous studies have
shown that the transcription factor HNF1 acts as a book-
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Figure 6. Thermo-sensitivity of MODY mutants is linked to a switch in DNA binding ability. (A) Electrophoretic mobility shift assays (EMSA) experi-
ments using 2 g of nuclear extracts from MDCK cells stably expressing Nter-HNF1-GFP WT or mutants, and variable amounts of double stranded
oligonucleotide probe (from 0.4 to 100 nM), at the indicated temperature. Probe: migration of the radioactive probe in the absence of protein. Nc: non-
specific competition, with a 30-fold excess of cold arbitrary and unrelated probe. Sc: specific competition, with a 30-fold excess of cold HNF1 probe. TOP:
position of the well. S: specific band-shift. NS: non-specific band-shift. F: free probe. (B) Saturation curves established after signal measurement on ImageJ.
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Figure 7. The switch inDNAbinding is a reversible phenomenon. (A)Western blot analysis of nuclear extracts fromMDCKcells expressingNter-HNF1-
GFP WT or mutants upon doxycycline induction. Protein extracts were incubated on ice, or at 38◦C, for 20 min, then directly resuspended in Laemmli
Buffer and boiled for 5 min. The negative control corresponds to nuclear extract of wild-type MDCK cells (NT). (B) EMSA using 3 g of nuclear extracts,
and different amounts of radioactive HNF1 probe (between 12.5 and 100 nM). Binding reactions were carried out at 38◦C. Half of the binding reaction
of the P256S was electrophoretically separated 38◦C, while the second half was incubated on ice for 20 min and then separated at 4◦C. (C) Live imaging
of MDCK cells stably expressing Nter-HNF1-GFP P256S (green signal) submitted to a first cold shock (COLD SHOCK 1), left to heat up to 37◦C and
submitted to a second cold shock (COLD SHOCK 2). White arrows indicate the position of the mitotic cells. Time (in minutes) is indicated for each frame
at the bottom right corner. Scale bar: 10 m.
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Figure 8. Importazole affects the dynamic relocalization of P256S mutant on mitotic chromatin. (A) Representative images of MDCK cells expressing
the P256S mutant stained with Hoechst (red signal, DNA) submitted to a cold shock, in the presence or absence of importazole. (B) Quantification of
the difference of the Intensity Correlation Quotient (ICQ) between Hoechst and GFP signal before and after cold shock, in cells treated or not with
importazole. Images after cold-shock were taken 1 min after addition of cold medium. White arrows indicate mitotic cells. Scale bars: 10 m. Results are
represented by mean ± SEM. Statistical significance betweenICQ for DMSO (n= 27) and Importazole (n= 30) treated cells was determined by a paired
t-test. **P < 0.001.
marking factor. Indeed, HNF1 is capable of binding to
mitotic chromatin and reactivating the expression of spe-
cific target genes after mitosis (8).
In the present study, we have demonstrated that the bind-
ing of HNF1 to mitotic chromatin requires an efficient
DNA binding ability. In fact, a series of deletions, known to
prevent DNA binding, significantly impairs this function.
Interestingly, specific point mutations leading to residue
substitutions (P256S and V265L), responsible for loss of
function phenotypes inMODY3 andMODY5 patients, ab-
rogate DNA binding and as a consequence, mitotic chro-
matin binding. All these results indicate that the mitotic
chromatin localization of HNF1 relies on its specific abil-
ity to bind to DNA. Interestingly, the analysed mutant
proteins (P256S and V265L) are characterized by thermo-
sensitive phenotypes. They bind to DNA only at tempera-
tures below specific critical threshold. These observations
indicate that these mutant proteins may exist in two alter-
native conformations with drastically different DNA bind-
ing capabilities that can rapidly interconvert one another ac-
cording to the temperature.
In this respect, wewere able to show that primaryURECs
from anHNF1B patient carrying a heterozygous P256Smu-
tation displayed a slight but significant decrease of HNF1
mitotic localization.Moreover, this defect was rescued upon
temperature decrease, further confirming the results we ob-
tained with the mutant HNF1 GFP-fusion proteins.
Our ChIP assay experiments showed that HNF1B mu-
tants were still able to bind the promoters of target genes
although to a slightly lesser extent compared to the wild-
type protein. In this regard, we cannot completely rule out
that the adopted experimental conditions for ChIP were
not able to prevent the conformational change that allows
the mutant GFP-fusion proteins to bind DNA at lower
temperatures. In fact, given the rapidity that characterizes
this binding switch/relocalization phenomenon we cannot
exclude that during the crosslinking step mutant proteins
might have suddenly recovered their permissive conforma-
tion. In addition, it has also been recently reported that pio-
neer transcription factors can target nucleosomes by recog-
nizing only partial DNA motifs (38). Thus, we cannot rule
out thatMODYmutants with decreasedDNAbinding abil-
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ities, as the ones described in this study, might still be able
to associate to DNA in a chromatin context, at least in in-
terphase chromatin.
The temperature sensitivity of our mutant proteins al-
lowed us to probe and assess their in vivo behaviour upon
sudden loss of DNA binding. Our results showed that mi-
totic chromatin binding during mitosis can be modulated
in a very highly dynamic way. In fact, it takes <1 min to
completely disperse a mutant protein in the cytoplasm if
the temperature is suddenly raised above a critical thresh-
old. This suggests that whenDNAbinding is suddenly com-
promised, HNF1 very rapidly diffuses in the surrounding
cytoplasm. On the other hand, a rapid temperature drop,
converting the mutant HNF1 into a DNA binding com-
patible conformation, leads to a surprising massive mitotic
chromatin recruitment and localization in <1 min.
Such a prompt response in localizationmight rely on very
efficient translocationmachineries. Interestingly, our results
have demonstrated that this translocation can be very ef-
ficiently inhibited, in already engaged mitotic cells, by a
short-lived (20 min) treatment with importazole, a known
inhibitor of the importin-machinery. This observation in-
dicates that mitotic chromatin localization of bookmarking
factors is probably helped by the importin system known to
be based on a Ran-GDP/Ran-GTP gradient that is main-
tained around mitotic chromatin during mitosis (36). It is
worth to note that importin- inhibition, per se, is not able
to prevent wild-type HNF1 from binding mitotic chro-
matin, indicating that when the protein is solidly bound,
importin- inhibition is not sufficient to displace the pro-
tein from mitotic chromosomes. All these observations in-
dicate that cells are genetically programmed with a system
to ensure the transport of HNF1 to mitotic chromatin.
Recent studies have indicated that bookmarking fac-
tors can be associated to mitotic chromatin in two dis-
tinct ways. The first one, DNA-sequence-specific, seems
to account for the association of transcription factors to
precise locations on the genome. The second one, non-
sequence specific, seems to ensure that bookmarking fac-
tors stay enriched in close proximity to mitotic chromatin
throughout the whole cell division process (5). Our results
seem to indicate that the action of bookmarking factors
might be mediated by a two-step process (Figure 9). In
the first step, an importin--dependent translocation would
ensure that bookmarking factors are translocated into the
proximity of mitotic chromatin. This enrichment is based
on the indirect active transport/translocation dependent
on the importin- and on the typical RanGTP-RanGDP
gradient/hydrolysis cycle that characterizes mitotic chro-
mosomes (39). The second step, requiring the sequence spe-
cific DNA binding activity of bookmarking transcription
factors, would allow the bookmarking of chromatin terri-
tories of specific target genes. This association, thermody-
namically more stable, would explain the fact that once as-
sociated to DNA, HNF1, for example, can remain asso-
ciated to mitotic chromatin for relatively long time without
requiring the importin- translocation system (Supplemen-
tary Figure S6). On the other hand, when the DNA bind-
ing activity is suddenly inactivated, the very abundant in-
ducible expression of the GFP-fusion mutant HNF1 pro-
teins, at restrictive temperatures, might possibly rapidly dis-
Figure 9. Model of association of HNF1 to mitotic chromatin. The lo-
calization of HNF1 on mitotic chromatin may be considered to be based
on a two-step process. In the first step, RAN-GTP gradient and Importin-
 system could bring HNF1 in close proximity to mitotic chromatin. In
the second step, the DNA-binding ability of HNF1 could provide a more
intimate and stable association of the protein with mitotic chromatin.
sipate the GTP/GDP gradient through a futile cycle of
translocation/diffusion process that eventually would dis-
perse the GFP fusion protein throughout the entire cyto-
plasm of mitotic cells. One of the possible consequences of
this phenomenon is the fact that our inducible expression
system is highly toxic since induced cells cannot survive the
expression of the HNF1-GFP fusion proteins more than
2–3 days.
The discrepancy between the localization of HNF1
GFP-fusion proteins in live cells versus that observed in
formaldehyde-fixed cells has disclosed the artefactual im-
pact of this type of fixation in the study of subcellular lo-
calization of transcription factors during mitosis. It has al-
ready been suggested that formaldehyde crosslinking may
not be necessarily appropriate for the study of chromatin
binding of specific set of proteins (40). Concerns about
formaldehyde crosslinking have also been previously raised
in the case of chromatin crosslinking experiments (41). In
the case of bookmarking factors, similar discrepancies have
already been described. For example,GATA1, a bookmark-
ing transcription factor involved in erythroid cell specifi-
cation, shows retention on mitotic chromosomes in live
cell-imaging (GFP fusion protein and ChIP experiment)
whereas upon Paraformaldehyde (PFA) fixation the protein
is globally dispersed in the cytoplasm during mitosis (6).
In a similar way, FOXA1, a hepatocyte transcription fac-
tor with bookmarking activity, shows the same discrepancy:
FOXA1 in fusion withGFP is perfectly localized onmitotic
chromatin in live cells, whereas when fixed with formalde-
hyde, the endogenously expressed protein exhibits a diffused
dispersion in indirect immunofluorescence experiments (5).
The discovery of alternative fixationmethodologies that can
preserve mitotic localizations could bring novel insights in
the study of binding of transcription factors tomitotic chro-
matin.
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In conclusion, our results highlight the crucial role played
by the DNA binding ability of HNF1 in the interaction
with mitotic chromatin. In this context, the importin- sys-
tem is likely to be involved in the maintenance and collec-
tion of HNF1 protein to mitotic chromatin. More impor-
tantly, our studies have provided experimental evidence that
defective mitotic chromatin binding may be responsible for
human pathological conditions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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